Hikma debuts generic AfinitorEverolimus tablets had a market value of roughly $435 million in the 12 months endedApril 2020, according to IQVIA. Dr. Reddy’s acquires Wockhardt's generics business divisions Dr. Reddy's is acquiring Wockhardt's branded generics, which include respiratory, neurology, VMS, dermatology, gastroenterology, pain and vaccines. Teva releases generic Afinitor Novartis is launching generic Afinitor tablets in dosage strengths of 2.5 mg, 5 mg and 7.5 mg. Leucadia launches generic Migranal Leucadia’s dihydroergotamine mesylate nasal spray is the first generic of Bausch Health’s Migranal. Q&A: Upsher-Smith CEO on operating during pandemic Rusty Field, president and CEO of Upsher-Smith Labs, spoke to Drug Store News about how it is operating, and efforts to stay on track with products. Novadoz gets FDA nod for generic Tamiflu, launches generic Tykosin The Oseltamivir phosphate brand and generic had a market value of roughly $188 million, while the dofetilide brand and generic had a market value of more than $63.4 million. Zydus Cadila gets FDA nod for generic Reyataz Zydus Cadila's atazanavir capsules will be available in dosage strengths of 150 mg, 200 mg and 300 mg. Q&A: Dillaway shares Ascend’s plan for bolstering infrastructure DSN spoke to John Dillaway, executive vice president at Ascend Labs, about how it is expanding while also navigating the COVID-19 pandemic. Lupin gets FDA blessing for generic Vivlodex Meloxicam capsules had a market value of roughly $14 million, according to IQVIA data from March. Strides receives FDA green light for triamcinolone acetonide Triamcinolone acetonide ointment, 0.05% had a market value of approximately $15 million, according to IQVIA. First Previous 156 157 158 159 160 Next Last
